Evaluate if Response to Infliximab or Adalimumab May be Regained With an Immunomodulator

NCT02413047 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped physician decision to stop study early due to low enrollment

Conditions

Inflammatory Bowel Disease
Ulcerative Colitis
Crohn's Disease

Interventions

DRUG: Azathioprine
DRUG: 6 mercaptopurine
DRUG: Methotrexate

Sponsor

Indiana University